Navigation Links
TPI Reports Fiscal Year 2013 Financial Results
Date:9/27/2013

strategies to stabilize our generic sales. In addition to the distribution revenue from TMT and JCM macrolide API revenue, we are also focusing on expanding sales efforts at tier 3 and tier 2 hospitals in major cities of China to strengthen our high-end hospital pharmaceutical market segment. Our top five products by sales in fiscal year 2013 are:

Product DescriptionAmountGinkgo Mihuan Oral Liquid (GMOL) for cardiovascular diseases$

26.1 millionMycophenolate mofetil capsules (MM) for renal transplant$

6.9 millionAzithromycin Dispersible Tablets (AZI) for infectious diseases$

4.6 millionQingre Jiedu Oral Liquid (QRE) for viral infections$

3.6 millionYanyan Tablets (YY) for throat inflammation$

1.6 millionThe core product portfolio totaled $42.7 million or 84% of the organic portfolio revenue.

Gross profit for fiscal year ended June 30, 2013 was approximately $26.0 million with 38.5% gross margins an increase of 7% year over year, compared with $24.3 million with 35.0% gross margin for fiscal year ended June 30, 2012. The improvement in gross margins was mainly attributable to the increase of the sales of GMOL by 53.0% year over year from $17.1 million in fiscal year 2012 to $26.1 million, along with other core products revenue growth that totaled $42.7 million with higher margins. This offset the prevailing generic pricing pressure and the lower margined TMT distribution revenues, whose gross margins average about 10%. During the fiscal year 2013, our organic product portfolio delivered approximately 51.6% gross margins, a significant improvement from 45.0% in fiscal year 2012. Provided the blend of core product sales growth along with TMT lower margin distribution revenue and lower margin generic sales as the current pricing trend continues, we anticipate our overall gross margin in the near term to stabilize above 36% for the fiscal 2014, influenced by the revenue mix of TMT revenue and JCM macroli
'/>"/>

SOURCE Tianyin Pharmaceutical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Substantial Reductions of Triglycerides and Apoc-III in Patients with Familial Chylomicronemia
2. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
3. Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy
4. InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results
5. Apollo Medical Holdings Reports Record Fiscal 2014 Second Quarter Results
6. Cyberonics Reports Inducement Equity Award Under NASDAQ Listing Rule 5635(c)(4)
7. Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
8. Omeros Reports Additional Positive Results from OMS824 Program
9. S&P Capital IQ Initiates Coverage on Epigenomics AG in Standard & Poors Factual Stock Reports
10. CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union
11. Market Research Reports: Biologics, Biosimilars, Bioseparation Systems for Biopharmaceutical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Calif. , April 16, 2015  Amgen (NASDAQ: ... its first quarter financial results on Tuesday, April 21, ... The announcement will be followed by a conference call ... in the call from Amgen will be Robert ... other members of Amgen,s senior management team. ...
(Date:4/16/2015)... Kenneth C. Frazier , chairman and chief executive officer ... the Board of the Pharmaceutical Research and Manufacturers of America ... John J. Castellani announced that he will be retiring ... to PhRMA Board Frazier formerly held the position ... and CEO of Pfizer, Inc. Also elected were George ...
(Date:4/16/2015)... , April 16, 2015  Rosewind Corporation (OTCMKTS: ... reverse merger with a newly formed specialty healthcare ... focus on addressing urological disorders. The merged company, ... Inc., has commenced operations and incorporates the pipeline ... The Company,s strategy is to build a late-stage ...
Breaking Medicine Technology:Amgen Announces Webcast Of 2015 First Quarter Financial Results 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3
... Calif., Dec. 19, 2011 Pharmacyclics, Inc. (Nasdaq: ... on developing and commercializing innovative small molecule drugs ... diseases, announced today issue notification from the United ... ) of a patent entitled "Inhibitors of Bruton,s ...
... 2011    , ... Gerresheimer invests around EUR 25 million in its ...   Gerresheimer AG, one of the world,s ... the growth market of complex plastic systems for pharmaceutical and medical ...
Cached Medicine Technology:Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent 2Pharmacyclics Inc. Receives Issue Notice of Significant Bruton's Tyrosine Kinase (BTK) Patent 3Gerresheimer Extends Production of Medical Plastic Systems in Bavaria 2
(Date:4/19/2015)... April 19, 2015 Women’s Excellence ... W. Dryden Road, Metamora, MI. 48455. They will be ... , Days and hours are Thursdays and Fridays from ... , Women’s Excellence is the most comprehensive obstetric and ... weight control, bladder control, endometriosis, robotic surgery, pelvic floor ...
(Date:4/19/2015)... 2015 Broccoli sprout extract protects against ... small group of healthy human volunteers, the University ... UPMC CancerCenter , announced today at the American ... Philadelphia. , The promising results will be further ... participants at high risk for head and neck cancer ...
(Date:4/19/2015)... (PRWEB) April 19, 2015 New court ... Litigation (JPML) indicate that Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) ... U.S. District Court, District of South Carolina. According to ... have been filed in the proceeding on behalf of ... their use of the cholesterol-lowering statin. This represents an ...
(Date:4/19/2015)... April 19, 2015 Family and friends of ... Brains in Memory of Brad Baddeley event to honor ... Foundation. , Bowling for Brains is cheduled to take place ... Dudley Street in Lincoln, Nebraska. Participants may arrive at 12:30pm ... 3:00pm. , The cost is only $4 per game and ...
(Date:4/18/2015)... Carinsurancequotesinfo.com has released a new blog post ... caused by a car accident. , Car ... vehicle. A policy can pay for car repairs and ... always carry appropriate coverage when they are driving. ... with several important riders that offer extra coverage options. ...
Breaking Medicine News(10 mins):Health News:Preventing Cancer with Broccoli Sprout Extract 2Health News:Preventing Cancer with Broccoli Sprout Extract 3Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 2Health News:Lipitor Lawsuits Mount, as New Court Report Shows More Than 100 Filings Added to Federal Litigation Since March 3Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 2Health News:Lincoln, NE’s Bowling for Brains to benefit Renowned Brain Aneurysm Foundation 3Health News:Auto Insurance Plans Can Cover Physical Injuries Caused By An Accident! 2
... ... Officers in MedeFile System During National ... Police Week, CEDAR ... specializing in,portable electronic medical records management solutions, today announced,that in collaboration with the ...
... -- Research findings and innovative approaches offer the promise ... adults living with type 1 diabetes, according to researchers ... Forum in Washington D.C. , Type 1 diabetes is ... insulin-producing beta cells in the pancreas. It renders ...
... A CI head once noted that,"Competitive Intelligence is like ... you realize you need it is when it is ... companies need competitive,intelligence to effectively deal with a turbulent ... that people begin to realize how,critical competitive intelligence is ...
... 18 Sunrise Senior Living,Inc. (NYSE: SRZ ), ... will present at the 2008 Jefferies 2nd Annual,Healthcare Conference ... 1:30 p.m.,Eastern Time. Sunrise will Web cast the presentation ... http://www.sunriseseniorliving.com ). A replay of the Web cast will ...
... Nursing Facility,Funding Cut, COLUMBUS, Ohio, June 18 ... American Health Care Association (AHCA) today,praised Ohio Congressman ... the growing bipartisan effort in Congress to prevent,the ... to,seniors, Medicare Part A nursing home funding - ...
... Inc.,(Nasdaq: HOLX ) today announced that Glenn Muir, ... Annual Healthcare Conference being,held June 24 - 26, 2008, ... Interested parties are invited to listen to a ... 25, 2008, at 12:30 PM.,Eastern Time on the investor ...
Cached Medicine News:Health News:MedeFile International Teams with Newark Fraternal Order of Police 2Health News:MedeFile International Teams with Newark Fraternal Order of Police 3Health News:MedeFile International Teams with Newark Fraternal Order of Police 4Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 2Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 3Health News:Build and Maintain an Effective Competitive Intelligence Group 2Health News:Boehner Thanked for Opposing Funding Cut to Medicare Beneficiaries 2Health News:Hologic to Present at the Jefferies 2nd Annual Healthcare Conference 2
... The STart benchtop coagulation analyzers ... electro-mechanical clot detection. This method ... or other optically dense samples ... programmable and preprogrammed assays with ...
... The STA is a fully-automated, coagulation ... and immunological assays in true random ... of sample management offers high throughput ... without the need to interrupt current ...
... The MLA 750 is an ... automated systems. Photometric end point detection ... clean because no electrodes are inserted ... is virtually impossible. The MLA 750 ...
The ACL 9000 together with an extensive test menu and superior technology is backed by high-quality service to keep the lab running efficiently....
Medicine Products: